{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T21:01:43Z","timestamp":1771275703754,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Japan Society for the Promotion of Science (JSPS) KAKENHI","award":["JP22K10137"],"award-info":[{"award-number":["JP22K10137"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00520-026-10346-1","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:41:30Z","timestamp":1768398090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and risks of drug holiday in the management of medication-related osteonecrosis of the jaw in cancer patients: a single-center retrospective study"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0077-7026","authenticated-orcid":false,"given":"Hironobu","family":"Hata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1090-3660","authenticated-orcid":false,"given":"Kenji","family":"Imamachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhito","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4055-9047","authenticated-orcid":false,"given":"Mayumi","family":"Kamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0220-0535","authenticated-orcid":false,"given":"Toshihisa","family":"Osanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8199-3037","authenticated-orcid":false,"given":"Masashi","family":"Matsuzaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobumoto","family":"Tomioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5839-2954","authenticated-orcid":false,"given":"Toru","family":"Harabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Oizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6080-3413","authenticated-orcid":false,"given":"Michihiro","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1825-1070","authenticated-orcid":false,"given":"Hiroaki","family":"Hiraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4642-8611","authenticated-orcid":false,"given":"Ikuya","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"10346_CR1","first-page":"4505","volume":"30","author":"H Hata","year":"2022","unstructured":"Hata H, Imamachi K, Ueda M, Matsuzaka M, Hiraga H, Osanai T, Harabayashi T, Fujimoto K, Oizumi S, Takahashi M, Yoshikawa K, Sato J, Yamazaki Y, Kitagawa Y (2022) Prognosis by cancer type and incidence of zoledronic acid-related osteonecrosis of the jaw: a single-center retrospective study. Support Care Cancer 30:4505\u20134514","journal-title":"Support Care Cancer"},{"key":"10346_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1634\/theoncologist.2010-0183","volume":"16","author":"RA Miksad","year":"2011","unstructured":"Miksad RA, Lai KC, Dodson TB, Woo SB, Treister NS, Akinyemi O, Bihrle M, Maytal G, August M, Gazelle GS, Swan JS (2011) Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist 16:121\u2013132","journal-title":"Oncologist"},{"key":"10346_CR3","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O\u2019Ryan F, American Association of O, Maxillofacial S (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update. J Oral Maxillofac Surg 72:1938\u20131956","journal-title":"J Oral Maxillofac Surg"},{"key":"10346_CR4","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","volume":"80","author":"SL Ruggiero","year":"2022","unstructured":"Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D (2022) American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws-2022 update. J Oral Maxillofac Surg 80:920\u2013943","journal-title":"J Oral Maxillofac Surg"},{"key":"10346_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.amjoto.2006.08.004","volume":"28","author":"C Magopoulos","year":"2007","unstructured":"Magopoulos C, Karakinaris G, Telioudis Z, Vahtsevanos K, Dimitrakopoulos I, Antoniadis K, Delaroudis S (2007) Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals. Am J Otolaryngol 28:158\u2013163","journal-title":"Am J Otolaryngol"},{"key":"10346_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.oooo.2015.10.033","volume":"121","author":"JP Bodem","year":"2016","unstructured":"Bodem JP, Schaal C, Kargus S, Saure D, Mertens C, Engel M, Hoffmann J, Freudlsperger C (2016) Surgical management of bisphosphonate-related osteonecrosis of the jaw stages II and III. Oral Surg Oral Med Oral Pathol Oral Radiol 121:367\u2013372","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"584\u2013594","key":"10346_CR7","volume":"148","author":"M El-Rabbany","year":"2017","unstructured":"El-Rabbany M, Sgro A, Lam DK, Shah PS, Azarpazhooh A (2017) Effectiveness of treatments for medication-related osteonecrosis of the jaw: A systematic review and meta-analysis. J Am Dent Assoc 148(584\u2013594):e582","journal-title":"J Am Dent Assoc"},{"key":"10346_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/08869634.2017.1365413","volume":"36","author":"SH Kang","year":"2018","unstructured":"Kang SH, Won YJ, Kim MK (2018) Surgical treatment of stage 2 medication-related osteonecrosis of the jaw compared to osteomyelitis. Cranio 36:373\u2013380","journal-title":"Cranio"},{"key":"10346_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s00774-019-01035-7","volume":"38","author":"S Hayashida","year":"2020","unstructured":"Hayashida S, Yanamoto S, Fujita S, Hasegawa T, Komori T, Kojima Y, Miyamoto H, Shibuya Y, Ueda N, Kirita T, Nakahara H, Shinohara M, Kondo E, Kurita H, Umeda M (2020) Drug holiday clinical relevance verification for antiresorptive agents in medication-related osteonecrosis cases of the jaw. J Bone Miner Metab 38:126\u2013134","journal-title":"J Bone Miner Metab"},{"key":"10346_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ajoms.2020.09.002","volume":"33","author":"T Yoshida","year":"2021","unstructured":"Yoshida T, Watanabe T, Akizuki S, Okishio Y, Fujikawa N, Mori A, Fukuhara S, Asai K, Bessho K (2021) Adverse events caused by the discontinuation of anti-resorptive agents during treatment for anti-resorptive agent-related osteonecrosis of the jaw: a single-center cohort study. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology 33:115\u2013119","journal-title":"Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology"},{"key":"10346_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.joms.2014.07.012","volume":"73","author":"AM Hinson","year":"2015","unstructured":"Hinson AM, Siegel ER, Stack BC Jr. (2015) Temporal correlation between bisphosphonate termination and symptom resolution in osteonecrosis of the jaw: a pooled case report analysis. J Oral Maxillofac Surg 73:53\u201362","journal-title":"J Oral Maxillofac Surg"},{"key":"10346_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2334\/josnusd.17-0027","volume":"60","author":"N Ohga","year":"2018","unstructured":"Ohga N, Sato J, Asaka T, Morimoto M, Yamazaki Y, Kitagawa Y (2018) Successful conservative treatment of jaw osteonecrosis caused by denosumab in patients with multiple bone metastasis. J Oral Sci 60:159\u2013162","journal-title":"J Oral Sci"},{"key":"10346_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051209","author":"S Okuma","year":"2020","unstructured":"Okuma S, Matsuda Y, Nariai Y, Karino M, Suzuki R, Kanno T (2020) A retrospective observational study of risk factors for denosumab-related osteonecrosis of the jaw in patients with bone metastases from solid cancers. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12051209","journal-title":"Cancers (Basel)"},{"key":"10346_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.joms.2009.01.006","volume":"67","author":"ER Carlson","year":"2009","unstructured":"Carlson ER, Basile JD (2009) The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 67:85\u201395","journal-title":"J Oral Maxillofac Surg"},{"key":"10346_CR15","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00432-010-0953-1","volume":"137","author":"T Mucke","year":"2011","unstructured":"Mucke T, Koschinski J, Deppe H, Wagenpfeil S, Pautke C, Mitchell DA, Wolff KD, Holzle F (2011) Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws. J Cancer Res Clin Oncol 137:907\u2013913","journal-title":"J Cancer Res Clin Oncol"},{"key":"10346_CR16","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jcms.2014.11.014","volume":"43","author":"O Ristow","year":"2015","unstructured":"Ristow O, Otto S, Troeltzsch M, Hohlweg-Majert B, Pautke C (2015) Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ). J Craniomaxillofac Surg 43:290\u2013293","journal-title":"J Craniomaxillofac Surg"},{"key":"10346_CR17","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","volume":"22","author":"S Khosla","year":"2007","unstructured":"Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, McCauley LK, McGowan J, McKee MD, Mohla S, Pendrys DG, Raisz LG, Ruggiero SL, Shafer DM, Shum L, Silverman SL, Van Poznak CH, Watts N, Woo SB, Shane E, American Society for B, Mineral R (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22:1479\u20131491","journal-title":"J Bone Miner Res"},{"key":"10346_CR18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0278-2391(09)01709-1","volume":"67","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B, American Association of O, Maxillofacial S (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20132009 update. J Oral Maxillofac Surg 67:2\u201312","journal-title":"J Oral Maxillofac Surg"},{"key":"10346_CR19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.joms.2008.09.037","volume":"67","author":"C Pautke","year":"2009","unstructured":"Pautke C, Bauer F, Tischer T, Kreutzer K, Weitz J, Kesting M, Holzle F, Kolk A, Sturzenbaum SR, Wolff KD (2009) Fluorescence-guided bone resection in bisphosphonate-associated osteonecrosis of the jaws. J Oral Maxillofac Surg 67:471\u2013476","journal-title":"J Oral Maxillofac Surg"},{"key":"10346_CR20","doi-asserted-by":"crossref","unstructured":"Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O'Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Al Dabagh R, Davison KS, Kendler DL, Sandor GK, Josse RG, Bhandari M, El Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J, International Task Force on Osteonecrosis of the J (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus J Bone Miner Res 30 3-23","DOI":"10.1002\/jbmr.2405"},{"key":"10346_CR21","first-page":"9693","volume":"30","author":"H Hata","year":"2022","unstructured":"Hata H, Imamachi K, Ueda M, Matsuzaka M, Hiraga H, Osanai T, Harabayashi T, Fujimoto K, Oizumi S, Takahashi M, Yoshikawa K, Sato J, Yamazaki Y, Kitagawa Y (2022) Prognosis of metastatic bone cancer and myeloma patients and long-term risk of medication-related osteonecrosis of the jaw (MRONJ): some critical points. Support Care Cancer 30:9693\u20139695","journal-title":"Support Care Cancer"},{"key":"10346_CR22","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.joms.2015.09.024","volume":"73","author":"SL Ruggiero","year":"2015","unstructured":"Ruggiero SL, Kohn N (2015) Disease stage and mode of therapy are important determinants of treatment outcomes for medication-related osteonecrosis of the jaw. J Oral Maxillofac Surg 73:S94\u2013S100","journal-title":"J Oral Maxillofac Surg"},{"key":"10346_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bone.2017.08.003","volume":"105","author":"E Tsourdi","year":"2017","unstructured":"Tsourdi E, Langdahl B, Cohen-Solal M, Aubry-Rozier B, Eriksen EF, Guanabens N, Obermayer-Pietsch B, Ralston SH, Eastell R, Zillikens MC (2017) Discontinuation of denosumab therapy for osteoporosis: a systematic review and position statement by ECTS. Bone 105:11\u201317","journal-title":"Bone"},{"key":"10346_CR24","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/jbmr.3110","volume":"32","author":"AD Anastasilakis","year":"2017","unstructured":"Anastasilakis AD, Polyzos SA, Makras P, Aubry-Rozier B, Kaouri S, Lamy O (2017) Clinical features of 24 patients with rebound-associated vertebral fractures after denosumab discontinuation: systematic review and additional cases. J Bone Miner Res 32:1291\u20131296","journal-title":"J Bone Miner Res"},{"key":"10346_CR25","doi-asserted-by":"publisher","first-page":"516","DOI":"10.7326\/M20-0882","volume":"173","author":"H Lyu","year":"2020","unstructured":"Lyu H, Yoshida K, Zhao SS, Wei J, Zeng C, Tedeschi SK, Leder BZ, Lei G, Tang P, Solomon DH (2020) Delayed denosumab injections and fracture risk among patients with osteoporosis: a population-based cohort study. Ann Intern Med 173:516\u2013526","journal-title":"Ann Intern Med"},{"key":"10346_CR26","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.4065\/81.8.1047","volume":"81","author":"MQ Lacy","year":"2006","unstructured":"Lacy MQ, Dispenzieri A, Gertz MA, Greipp PR, Gollbach KL, Hayman SR, Kumar S, Lust JA, Rajkumar SV, Russell SJ, Witzig TE, Zeldenrust SR, Dingli D, Bergsagel PL, Fonseca R, Reeder CB, Stewart AK, Roy V, Dalton RJ, Carr AB, Kademani D, Keller EE, Viozzi CF, Kyle RA (2006) Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma. Mayo Clin Proc 81:1047\u20131053","journal-title":"Mayo Clin Proc"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10346-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10346-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10346-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:03:07Z","timestamp":1771272187000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10346-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10346"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10346-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"14 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed on human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This single-center, retrospective, observational study protocol and patient information were approved by the Hokkaido Cancer Center Hospital Ethics Review Board (clinical study number 03\u201363), and informed consent was waived by this board because of the retrospective design of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}